» Articles » PMID: 34858881

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma

Overview
Date 2021 Dec 3
PMID 34858881
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Microbial imbalances have been well elucidated in esophageal adenocarcinoma. However, few studies address the microbiota in esophageal squamous cell carcinoma (ESCC) and esophagitis (ES). We aimed to explore the association of esophageal microbiota with these patients. Esophageal tissues were obtained from healthy controls and ES and ESCC patients undergoing upper endoscopy. 16S rRNA gene sequencing was applied to analyze the microbiome. The α and β diversity differences were tested by Tukey test and partial least squares-discriminant analysis (PLS-DA), respectively. Linear discriminant analysis effect size (LEfSe) analysis was performed to assess taxonomic differences between groups. A total of 68 individuals were enrolled (control = 21, ES = 15, ESCC = 32). Microbial diversity was significantly different between the ESCC patients and healthy controls by Chao1 index, Shannon index, and PLS-DA. , , , , and were the five dominant bacterial phyla among the three groups. , , , and showed a significantly continuous decreasing trend from the control group to the ESCC group at the genus level. When compared with the control group, decreased at phylum level and , , , and at genus level were detected. ESCC samples also displayed a striking reduction of , , , and in comparison with the ES patients. LEfSe analysis indicated a greater abundance of , , , , and in the ESCC group. Our study suggests a potential association between esophageal microbiome dysbiosis and ESCC and provides insights into potential screening markers for esophageal cancer.

Citing Articles

Microbiota and Radiotherapy: Unlocking the Potential for Improved Gastrointestinal Cancer Treatment.

Vucinic D, Redzovic A, Hauser G, Mikolasevic I Biomedicines. 2025; 13(2).

PMID: 40002939 PMC: 11852588. DOI: 10.3390/biomedicines13020526.


Mechanistic Insights on Microbiota-Mediated Development and Progression of Esophageal Cancer.

Moe K, Tan K Cancers (Basel). 2024; 16(19).

PMID: 39409925 PMC: 11475040. DOI: 10.3390/cancers16193305.


Efficacy and safety evaluation of first-line systemic treatments for unresectable esophageal squamous cell carcinoma: a network meta-analysis.

Shi H, Tan Y, Ma C, Wei Y, Shi F, Wang J Front Oncol. 2024; 14:1397960.

PMID: 39314629 PMC: 11416913. DOI: 10.3389/fonc.2024.1397960.


Mechanism of action of FoxiangSan in diabetic gastroparesis: Gut microbiota and cAMP/PKA pathway.

Huang J, Song Y, Cheng S, Yang X Heliyon. 2024; 10(16):e35558.

PMID: 39211931 PMC: 11357790. DOI: 10.1016/j.heliyon.2024.e35558.


Gut Microbiota-Induced Modulation of the Central Nervous System Function in Parkinson's Disease Through the Gut-Brain Axis and Short-Chain Fatty Acids.

Ni Y, Tong Q, Xu M, Gu J, Ye H Mol Neurobiol. 2024; 62(2):2480-2492.

PMID: 39134825 DOI: 10.1007/s12035-024-04370-7.


References
1.
Rubinstein M, Wang X, Liu W, Hao Y, Cai G, Han Y . Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013; 14(2):195-206. PMC: 3770529. DOI: 10.1016/j.chom.2013.07.012. View

2.
Valguarnera E, Bubeck Wardenburg J . Good Gone Bad: One Toxin Away From Disease for Bacteroides fragilis. J Mol Biol. 2019; 432(4):765-785. DOI: 10.1016/j.jmb.2019.12.003. View

3.
Garrett W . Cancer and the microbiota. Science. 2015; 348(6230):80-6. PMC: 5535753. DOI: 10.1126/science.aaa4972. View

4.
Narikiyo M, Tanabe C, Yamada Y, Igaki H, Tachimori Y, Kato H . Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer Sci. 2004; 95(7):569-74. PMC: 11159681. DOI: 10.1111/j.1349-7006.2004.tb02488.x. View

5.
Marmol I, Sanchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi M . Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int J Mol Sci. 2017; 18(1). PMC: 5297828. DOI: 10.3390/ijms18010197. View